国际癌症报告合作组织肺癌切除标本病理报告数据集
国际癌症报告合作组织(ICCR)召集九名肺病理学家和一名肿瘤学家组成专家组,基于预定证据等级和专家共识,制定了肺癌切除标本病理报告指南,包含核心和非核心要素,涵盖临床、大体、镜下及辅助检测,并纳入2021年WHO胸部肿瘤分类第五版的变化、浸润性非黏液腺癌分级、新辅助治疗反应评估及早期切除肺癌分子检测要求。
要点
- 推荐对所有肺癌切除标本的病理报告常规使用ICCR数据集。
- 数据集包含核心要素和非核心要素,基于证据等级和专家共识确定。
- 纳入2021年WHO胸部肿瘤分类第五版的变化及浸润性非黏液腺癌分级新要求。
核心结论
- ICCR肺癌数据集整合了肺癌切除标本组织学报告的所有相关参数,推荐常规用于所有肺癌切除标本的病理报告。
研究设计与样本
- 采用ICCR既定程序,召集由九名肺病理学家和一名肿瘤学家组成的国际专家小组。
- 基于预定证据等级和专家共识确定核心要素和建议的非核心要素。
主要发现
- 制定了包含相关临床、大体、镜下和辅助检测的肺癌组织病理学报告指南。
- 数据集纳入2021年WHO胸部肿瘤分类第五版的变化、浸润性非黏液腺癌分级新要求、新辅助治疗反应评估及早期切除肺癌分子检测要求。
临床怎么用
- 推荐所有肺癌切除标本的病理报告常规使用该数据集。
- 数据集在全球ICCR网站免费获取,广泛实施有助于确保一致和全面的病理报告及数据收集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lung cancer is the leading cause of cancer related deaths worldwide, although some patients with early-stage disease can be cured with surgical resection. Standardised reporting of all clinically relevant pathological parameters is essential for best patient care and is also important for ongoing data collection and refinement of important pathological features that impact patient prognosis, staging and clinical care. Using the established International Collaboration on Cancer Reporting (ICCR) procedure, a representative international expert panel of nine lung pathologists as well as an oncologist was convened. Essential core elements and suggested non-core elements were identified for inclusion in the resected lung cancer pathology data set based on predetermined levels of evidence as well as consensus expert opinion. A lung cancer histopathology reporting guide was developed that includes relevant clinical, macroscopic, microscopic and ancillary testing. Critical review and discussion of current evidence was incorporated into the new data set including changes from the 2021 World Health Organisation (WHO) Classification of Thoracic Tumours, fifth edition, new requirements for grading invasive non-mucinous adenocarcinomas, assessment of response to neoadjuvant therapy and requirements for molecular testing in early-stage resected lung carcinomas. This ICCR data set represents incorporation of all relevant parameters for histology reporting of lung cancer resection specimens. Routine use of this data set is recommended for all pathology reporting of resected lung cancer and it is freely available worldwide on the ICCR website (https://www.iccr-cancer.org/datasets/published-datasets/). Widespread implementation will help to ensure consistent and comprehensive pathology reporting and data collection essential for lung cancer patient care, clinical trials and other research.
引用
- Cooper WA, Webster F, Butnor KJ, et al. Data set for the reporting of lung cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2024. PMID: 39438780. doi:10.1111/his.15313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。